Clinical Trial

Evaluating the Impact of Single Dose Tiotropium on Allergen-induced Early Asthmatic Response

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Evaluate single dose (2 x 2.5mcg/puff; total dose 5mcg) effect of tiotropium administered 30 minutes prior to allergen challenge on allergen-induced EAR assessed as the maximal % fall in FEV1 after allergen inhalation compared to that of single dose (two puffs) matched placebo administered 30 minutes prior to allergen challenge.
Trial Details
NCT Number NCT06679465
Lead Sponsor University of Saskatchewan
Conditions Asthma Bronchiale
Enrollment 10 participants
Start Date 2025-01-01
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-07